Future directions for clinical research with CPT-11 (irinotecan).
about
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinomaA multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumorsComparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity
P2860
Future directions for clinical research with CPT-11 (irinotecan).
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Future directions for clinical research with CPT-11 (irinotecan).
@en
type
label
Future directions for clinical research with CPT-11 (irinotecan).
@en
prefLabel
Future directions for clinical research with CPT-11 (irinotecan).
@en
P1476
Future directions for clinical research with CPT-11 (irinotecan).
@en
P2093
D von Hoff
P356
10.1016/0959-8049(96)00291-2
P478
32A Suppl 3
P577
1996-01-01T00:00:00Z